Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vittamed was a medical technology company that developed non-invasive ultrasonic devices for monitoring intracranial pressure (ICP) and cerebrovascular autoregulation. The company's core technology utilized ultrasound to measure ICP through the eye's ophthalmic artery, providing a safer alternative to invasive surgical sensors that require burr-hole surgery. Their primary products, the Vittamed 205 and Vittamed 505, were designed for clinical use in neuro-intensive care, neurology, and ophthalmology. While the company achieved CE Mark approval and collaborated with organizations like NASA to study intracranial pressure in astronauts, it is no longer active in the market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vittamed.